(PharmaNewsWire.Com, April 19, 2019 ) The “Global High Flow Nasal Cannula Market Analysis to 2025” is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global high flow nasal cannula market with detailed market segmentation by component, application, end user and geography. The global high flow nasal cannula market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The key players influencing the market are Resmed, Salter Labs, Fisher & Paykel Healthcare Limited, Teijin Pharma Limited, Vapotherm, BD, Great Group Medical Co., Ltd., Hamilton Medical, TNI Medical AG, Mek-Ics Co., Ltd.
The market of high flow nasal cannula market is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing prevalence and incidence of respiratory disorders asthma, chronic bronchitis, pleural effusion in the global population, rising funds in programs of research and development. Various technical advancement in the healthcare industry in Asia Pacific and Europe are expected to offer growth opportunities for the players operating in the market.
High-flow nasal cannula likely supports respiration although reduced inspiratory resistance, washout of the nasopharyngeal dead space, reduced metabolic work related to gas conditioning, improved airway conductance and mucociliary clearance and provision of low levels of positive airway pressure . Most data describing high-flow nasal cannula use in children focuses on those with bronchiolitis, although high-flow nasal cannula has been used in children with other respiratory diseases.
North America is expected to contribute to the largest share in the high flow nasal cannula market in the coming years, owing to factors such as, rising number of respiratory disorders, growing reimbursement policies and awareness about its treatment in United States and Canada. Asia Pacific is expected to witness significant growth rate during the forecast period primarily due to the enhanced policies of health care and the rapid growth in economic sector in the region of Asian countries such as, India, China and Japan.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global high flow nasal cannula market based on component, application, end user and geography. It also provides market size and forecast till 2025 for overall high flow nasal cannula market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
